September 24, 2020
Fujifilm Toyama Chemical said on September 23 that its antiviral agent Avigan (favipiravir) achieved the primary endpoint in a Japanese PIII trial covering patients infected with the novel coronavirus. The drug maker aims to file for this indication as early...read more